X
17Aug

An Update on Poison Pills, NOL Poison Pills and the COVID-19 Pandemic

Since the release of our recent article “Poison Pills, NOL Poison Pills and the COVID-19 Pandemic” in midApril, we continue to see a surge in the number of companies implementing poison pills (also referred to as shareholder rights plans), a type of defensive tactic used by a corporation’s board of directors against a hostile takeover bid. Please see full Publication below for more information....
By: Robinson & Cole LLP
Source Url: https://www.jdsupra.com/legalnews/an-update-on-poison-pills-nol-poison-25390/

Related

[Video] Daily Compliance News: August 11, 2019 Sunday Book Review edition

In today’s edition Sunday Book Review edition of Daily Compliance News: The Peterloo Massacre-Robe...

Read More >

[Video] Compliance Man Chooses the Target-Episode 4: Industrial & Consumer Goods

Welcome to Episode 4 of Compliance Man Chooses the Target with Tim Khasanov-Batirov. My goal is to h...

Read More >

A General Counsel’s View of Arbitration Clauses in Employee Contracts

Litigation has its place, but most in-house counsel agree: avoid it if at all possible. That’s why ...

Read More >

Healthcare & Life Sciences Private Equity Deal Tracker: NovaQuest Acquires CoreRx

NovaQuest Private Equity has announced it has acquired CoreRx. CoreRx, based in Clearwater, Fla.,...

Read More >

Party of One: Collective Action Against Outback Steakhouse Denied due to Lack of Personal Jurisdiction

The U.S. District Court for the District of Massachusetts denied conditional class action certificat...

Read More >

Let’s make a deal: New NOL regulations provide M&A relief for consolidated groups seeking to utilize CARES Act NOL carryback provisions

On July 2, 2020, the IRS issued proposed and temporary regulations under section 1502 that implement...

Read More >